"Immune mechanisms in fibrotic pulmonary sarcoidosis". P. Weeratunga, D.R. Moller and L-P. Ho. <i>Eur Respir Rev</i> 2022; 31: 220178.

Authors:
NA

Journal:
Eur Respir Rev

Publication Year: 2023

DOI:
10.1183/16000617.5178-2022

PMCID:
PMC10445105

PMID:
37611949

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Eur Respir Rev

Abbreviation: Eur Respir Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
An update on diagnosis and management of obstructive sleep apnoea in the first 2 years of life.
Polytarchou A; Moudaki A; Van de Perck E and 4 more (2024) - Transparency Score: 2/6
Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart dise…
van de Veerdonk MC; Roosma L; Trip P and 4 more (2024) - Transparency Score: 2/6
Eradication treatment for <i>Pseudomonas aeruginosa</i> infection in adults with bronchiectasis: a …
Conceição M; Shteinberg M; Goeminne P and 2 more (2024) - Transparency Score: 3/6
From treatable traits to GETomics in airway disease: moving towards clinical practice.
Papi A; Faner R; Pavord I and 6 more (2024) - Transparency Score: 3/6
Lung cancer risk and occupational pulmonary fibrosis: systematic review and meta-analysis.
Krabbe J; Steffens KM; Drießen S and 1 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
1/6
16.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025